10 January 2024
Nucala (mepolizumab) approved in China for use in severe asthma with an eosinophilic phenotype · Mepolizumab is the first targeted anti-Interleukin-5 (IL-5) biologic available in China…
10 January 2024 Assura plc Trading Update For the third quarter ending 31 December 2023 Assura plc (“Assura”), the leading primary care property investor…
10 January 2024 Advanced Medical Solutions Group plc (“AMS” or the “Group”) Full Year 2023 Trading Update In line with expectations for FY 2023…
FY23 Trading Update and Appointment of Non-Executive Director FY23 Adjusted Profit Before Tax anticipated to be above market expectations Nichols plc, the diversified soft…
NWF Group plc NWF Group plc: Acquisition of lease and Notice of Half Year Results Third warehouse marks further significant expansion of Food division…
10 January 2024 Third Quarter Trading Statement for the 16 weeks to 6 January 2024 Grocery volume growth driving continued market outperformance Trading Highlights…
10 January 2024 PENNON GROUP PLC ACQUISITION OF SUTTON AND EAST SURREY WATER Pennon Group plc (“Pennon”, the “Group” or the “Company”) is…
10 January 2024 GREGGS PLC (“Greggs” or the “Company”) Q4 TRADING UPDATE Further strong trading through fourth quarter Q4 highlights · Financial year 2023* (“FY23”)…